Picture of Enzymatica AB (publ) logo

ENZY Enzymatica AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Enzymatica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
C2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSInterim ReportARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-41.7-12.1-45.2-68.2-48.1
Depreciation
Non-Cash Items0.429-0.779-1.37.20.256
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.43-4.844.05-4.431.01
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-37.6-10.7-35.9-65.4-40.3
Capital Expenditures-0.866-4.84-6.13-3.72-0.73
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Cash from Investing Activities-0.866-4.84-6.13-3.72-0.73
Financing Cash Flow Items-0.1440-4.21-5.70
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2.531049.588.2-1.39
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-41-5.37.619.1-42.3